Collected Wisdom

This week we look at CSL, Ten Network Holdings, Sonic Healthcare, Fletcher Building and Federation Centres.

Summary: Analysts believe CSL’s latest purchase of flu treatment RAPIVAB neatly compliments the company’s flu vaccine business, but they don’t think Foxtel’s stake in Ten Network will be enough to offset concerns over the free-to-air network’s increasing competition. Sonic Healthcare’s acquisition of Swiss-based Medisupport was done at a good deal, building materials manufacturer Fletcher Building faces significant challenges ahead and Federation Centres has an attractive yield but is relatively high risk, analysts say.

Key take-out:  Analysts call CSL a “buy” following the purchase of the exclusive rights to commercialise RAPIVAB, with an average 12-month price target of $99.80 – 14 per cent above current levels.

{{content.question}}

{{ twilioFailed ? 'SMS Code Failed to Send…' : 'SMS Code Sent…' }}

Hi {{ user.FirstName }}

Looks like you've already taken a free trial

Please enter your payment details

We have sent you a code via SMS to {{user.DayPhone}}

please enter this code below to activate your membership

We cannot send you a code via SMS to {{user.DayPhone}}

If you didn't receive SMS code please

SMS code cannot be sent due to: {{ twilioStatus }}

Please select one of the options below:

Looks you are already a member. Please enter your password to proceed

Please untick this box when using a public or shared device


Verify your mobile number to unlock a FREE trial

Please sign up for full access

Updating information

Please wait ...

  • Mastercard
  • Visa
Mastercard

The email address you entered is registered with InvestSMART.

Please login or select "Don't know password"

Please untick this box when using a public or shared device


Register as a new member

(using a different email)

Related Articles